Management of women with multiple sclerosis through pregnancy and after childbirth

by Patricia K. Coyle
Published 2016-05-01

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

by Patricia K. Coyle
Published 2017-01-01

A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic...

by R de Verteuil, M Imamura, S Zhu, C Glazener, C Fraser, N Munro, J Hutchison, A Grant, D Coyle, K Coyle, L Vale
Published 2008-06-01

Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD

by M Trapero-Bertran, C Muñoz, K Coyle, D Coyle, A Lester-George, R Leidl, N Bertalan, KL Cheung, S Pokhrel, A Lopez-Nicolás
Published 2018-06-01

Estimating costs for modelling return on investment from smoking cessation interventions

by M Trapero-Bertran, R Leidl, C Muñoz, P Kulchaitanaroaj, K Coyle, M Präger, J Józwiak-Hagymásy, KL Cheung, M Hiligsmann, S Pokhrel, on behalf of the EQUIPT Study Group
Published 2018-06-01

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis

by Giancarlo Comi, Mark S. Freedman, José E. Meca-Lallana, Patrick Vermersch, Byoung Joon Kim, Alexander Parajeles, Keith R. Edwards, Ralf Gold, Houari Korideck, Jeffrey Chavin, Elizabeth M. Poole, Patricia K. Coyle
Published 2020-10-01

Gray matter is targeted in first-attack multiple sclerosis.

by Steven E Schutzer, Thomas E Angel, Tao Liu, Athena A Schepmoes, Fang Xie, Jonas Bergquist, László Vécsei, Denes Zadori, David G Camp, Bart K Holland, Richard D Smith, Patricia K Coyle
Published 2013-01-01

Establishing the proteome of normal human cerebrospinal fluid.

by Steven E Schutzer, Tao Liu, Benjamin H Natelson, Thomas E Angel, Athena A Schepmoes, Samuel O Purvine, Kim K Hixson, Mary S Lipton, David G Camp, Patricia K Coyle, Richard D Smith, Jonas Bergquist
Published 2010-06-01

Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome.

by Steven E Schutzer, Thomas E Angel, Tao Liu, Athena A Schepmoes, Therese R Clauss, Joshua N Adkins, David G Camp, Bart K Holland, Jonas Bergquist, Patricia K Coyle, Richard D Smith, Brian A Fallon, Benjamin H Natelson
Published 2011-02-01